"The
Report Diffuse Large B-Cell Lymphoma Global Clinical Trials Review,
H1, 2016 provides information on pricing, market analysis, shares,
forecast, and company profiles for key industry participants. -
MarketResearchReports.biz"
GlobalData's
clinical trial report, Diffuse
Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2016"
provides an overview of Diffuse Large B-Cell Lymphoma clinical trials
scenario. This report provides top line data relating to the clinical
trials on Diffuse Large B-Cell Lymphoma. Report includes an overview
of trial numbers and their average enrollment in top countries
conducted across the globe. The report offers coverage of disease
clinical trials by region, country (G7 & E7), phase, trial
status, end points status and sponsor type. Report also provides
prominent drugs for in-progress trials (based on number of ongoing
trials). GlobalData Clinical Trial Reports are generated using
GlobalDatas proprietary database - Pharma eTrack Clinical trials
database. Clinical trials are collated from 80+ different clinical
trial registries, conferences, journals, news etc across the globe.
Clinical trials database undergoes periodic update by dynamic
process.
The
report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
Download Sample copy of this
Report at : http://www.marketresearchreports.biz/sample/sample/743142
Scope
-
The report provides a snapshot of the global clinical trials
landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor
Type and End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months
Reasons to buy
-
Assists in formulating key business strategies with regards to
investment
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
-
Aids in interpreting the success rates of clinical trials by
providing a comparative scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level
Follow us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average
Enrollment by Country 7
Top Five Countries Contributing
to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing
to Clinical Trials in Europe 10
Top Countries Contributing to
Clinical Trials in North America 11
Top Five Countries Contributing
to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing
to Clinical Trials in Central and South America 13
Clinical Trials by G7
Countries: Proportion of Diffuse Large B-Cell Lymphoma to Oncology
Clinical Trials 14
Clinical Trials by Phase in G7
Countries 15
Clinical Trials in G7 Countries
by Trial Status 16
Clinical Trials by E7
Countries: Proportion of Diffuse Large B-Cell Lymphoma to Oncology
Clinical Trials 17
Clinical Trials by Phase in E7
Countries 18
Clinical Trials in E7 Countries
by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status
22
Clinical Trials by End Point
Status 23
Subjects Recruited Over a
Period of Time 24
Clinical Trials by Sponsor Type
25
Prominent Sponsors 26
Top Companies Participating in
Diffuse Large B-Cell Lymphoma Therapeutics Clinical Trials 27
Prominent Drugs 29
Latest Clinical Trials News on
Diffuse Large B-Cell Lymphoma 30
May 24, 2016: Novel
immunotherapy trial for lymphoma offers hope to patients at Sylvester
30
May 18, 2016: ProNAi to Report
Wolverine Phase 2 Interim Results on June 6th at ASCO 30
May 12, 2016: Epizyme to
Present Data From the Tazemetostat Non-Hodgkin Lymphoma Program at
American Society for Hematology Meeting on Lymphoma Biology 31
Apr 13, 2016: CTI BioPharma
Announces Presentation on pixantrone at the American Association of
Cancer Research Annual Meeting 31
Apr 11, 2016: Curis Announces
Presentation of Preclinical Data for CA-4948 at AACR Annual Meeting
32
Apr 06, 2016: MorphoSys
Initiates Phase 2 Combination Trial of MOR208 and Lenalidomide in
Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma 32
Apr 04, 2016: Curis Announces
Publication of CUDC-907 Phase 1 Clinical Trial Data in Lancet
Oncology 32
Mar 09, 2016: U.S. FDA Lifts
Partial Clinical Hold on Medivation Pidilizumab 33
Mar 09, 2016: Genmab Achieves
Second Milestone in Daratumumab NHL Study Under Collaboration with
Janssen 33
Mar 01, 2016: RedHill Biopharma
Provides Update on YELIVA 34
Clinical Trial Profile
Snapshots 35
Appendix 861
Abbreviations 861
Definitions 861
Research Methodology 862
Secondary Research 862
About GlobalData 863
Contact Us 863
Disclaimer 863
Source 864
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment